Platelet-rich plasma versus autologous whole blood for chronic lateral elbow epicondylitis .
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(3):66 Am J Sports Med; 2011; 39(10): 2130-213428 patients with chronic lateral epicondylitis were randomized to receive treatment with either a single injection of 3mL autologous blood or 3mL of platelet rich plasma (PRP) under ultrasound guidance. Patients who received PRP displayed greater VAS pain score improvement at all follow-up visits; however, significance was only observed at 6 week follow up. Additionally, it was found that there were no significant differences in range of motion and performance of daily activities between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
